Klaus O. Schafer's most recent trade in Altimmune Inc was a trade of 34,900 Stock Options (option to buy) done . Disclosure was reported to the exchange on Sept. 26, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Altimmune Inc | Klaus O. Schafer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Sep 2024 | 34,900 | 34,900 | - | - | Stock Options (option to buy) | |
Altimmune Inc | Schafer Klaus O. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Sep 2023 | 26,100 | 26,100 | - | - | Stock Options (option to buy) | |
Altimmune Inc | Klaus O. Schafer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jun 2022 | 159 | 0 | - | - | Stock Options (option to buy) | |
Altimmune Inc | Klaus O. Schafer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.40 per share. | 20 Jun 2022 | 159 | 9,119 (0%) | 0% | 2.4 | 382 | Common Stock, par value $0.0001 |
Altimmune Inc | Klaus O. Schafer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.40 per share. | 20 Jun 2022 | 60 | 8,960 (0%) | 0% | 2.4 | 144 | Common Stock, par value $0.0001 |
Altimmune Inc | Klaus O. Schafer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jun 2022 | 60 | 0 | - | - | Stock Options (option to buy) | |
Altimmune Inc | Klaus O. Schafer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.40 per share. | 20 Jun 2022 | 60 | 9,179 (0%) | 0% | 2.4 | 144 | Common Stock, par value $0.0001 |
Altimmune Inc | Klaus O. Schafer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jun 2022 | 60 | 0 | - | - | Stock Options (option to buy) | |
Altimmune Inc | Klaus O. Schafer | Director | Purchase of securities on an exchange or from another person at price $ 11.99 per share. | 10 Dec 2020 | 2,000 | 8,900 (0%) | 0% | 12.0 | 23,980 | Common Stock, par value $0.0001 |
Altimmune Inc | Klaus O. Schafer | Director | Sale of securities on an exchange or to another person at price $ 9.91 per share. | 12 Nov 2020 | 10,150 | 6,900 (0%) | 0% | 9.9 | 100,587 | Common Stock, par value $0.0001 |
Altimmune Inc | Klaus O. Schafer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Sep 2020 | 25,500 | 25,500 | - | - | Stock Options (option to buy) | |
Altimmune Inc | Klaus O. Schafer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Sep 2020 | 16,850 | 0 | - | - | Restricted Stock Units ("RSUs") | |
Altimmune Inc | Klaus O. Schafer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Sep 2020 | 16,850 | 17,050 (0%) | 0% | 0 | Common Stock, par value $0.0001 | |
Altimmune Inc | Klaus O. Schafer | Director | 25 Jun 2020 | 16,850 | 16,850 | - | - | Restricted Stock Units ("RSUs") |